Medical Policies
Home
Search Bar
Category Filter
Policies & Guidelines
Behavioral Health
Chronic Condition Management
Hemophilia Drugs
Draft Hemophilia Drug Policies
Final Hemophilia Drug Policies
Hemophilia Drug Prior Authorization
Medical Policies
Draft Medical Policies
Final Medical Policies
Pre-Service Review (Precertification and Predetermination)
Provider-Administered Drug Policies
Draft Provider-Administered Drug Policies
Final Provider-Administered Drug Precertification Policies
Mandatory Site of Service
Provider-Administered Drug Claim Edit Policies
Voluntary Site of Service
Self-Administered Drug Policies
Draft Self-Administered Drug Policies
Final Self-Administered Drug Policies
Self-Administered Drug Prior Authorization Forms
Asset Publisher
< Back to Final Medical Policies page
Final Policies - OB/GYN
Policy #
Policy Title
Print View
MP-016
Ultrasounds in Pregnancy
MP-095
Speculoscopy
MP-209
Levonorgestrel-releasing Intrauterine System (LNG-IUS) (Mirena®) for Heavy Menstrual Bleeding
MP-210
Surgical Interruption of Pelvic Nerve Pathways for Primary and Secondary Dysmenorrhea
MP-223
Home Care for High-Risk Maternity
MP-231
Fetal Echocardiography and Magnetocardiography
MP-232
Biophysical Fetal Profile
MP-233
First-Trimester Detection of Down Syndrome Using Fetal Ultrasound Markers Combined with Maternal Serum Assessment
Hidden